BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 417948)

  • 1. Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma androstenedione, testosterone, and testosterone binding in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Apr; 29(4):388-96. PubMed ID: 417948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma cortisol and cortisol binding in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1977 Nov; 28(11):1182-90. PubMed ID: 411689
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oral contraceptives on hormonal cytology.
    Kauraniemi TV; Hirvonen E
    Ann Chir Gynaecol Fenn; 1974; 63(6):465-9. PubMed ID: 4441026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen potency of oral contraceptive pills.
    Chihal HJ; Peppler RD; Dickey RP
    Am J Obstet Gynecol; 1975 Jan; 121(1):75-83. PubMed ID: 1115120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scanning electron microscopic study of the human fallopian tube. 3. The effect of midpregnancy and of various steroids.
    Patek E; Nilsson L; Johannisson E; Hellema M; Bout J
    Fertil Steril; 1973 Jan; 24(1):31-43. PubMed ID: 4685659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol.
    Kharma K; Stone S; Thorneycroft IH; Nakamura RM; Mishell DR
    Am J Obstet Gynecol; 1972 Mar; 112(5):676-80. PubMed ID: 4110418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroids and thyroid function tests: the role of estrogen and progestogen.
    Miyamoto J
    Int J Gynaecol Obstet; 1978; 16(1):28-33. PubMed ID: 83257
    [No Abstract]   [Full Text] [Related]  

  • 13. The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women.
    Givens JR; Andersen RN; Wiser WL; Umstot ES; Fish SA
    Am J Obstet Gynecol; 1976 Feb; 124(4):333-9. PubMed ID: 1251854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids and sex hormone-binding globulin.
    Tafurt CA; Sobrevilla LA; de Estrada R
    Fertil Steril; 1980 Mar; 33(3):261-6. PubMed ID: 6767626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
    Barbosa J; Seal US; Doe RP
    J Clin Endocrinol Metab; 1973 Apr; 36(4):706-14. PubMed ID: 4119677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency of progestogens in oral contraceptives--further delay of menses data.
    Swyer GI
    Contraception; 1982 Jul; 26(1):23-7. PubMed ID: 7128131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration.
    Granger LR; Roy S; Mishell DR
    Am J Obstet Gynecol; 1982 Nov; 144(5):578-84. PubMed ID: 6890312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha fetoprotein levels in women taking oral contraceptives.
    Seppälä M
    Int J Fertil; 1973; 18(4):206-8. PubMed ID: 4359688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.